The University of Southampton
University of Southampton Institutional Repository

Rosacea-like eruption due to topical pimecrolimus

Rosacea-like eruption due to topical pimecrolimus
Rosacea-like eruption due to topical pimecrolimus

Topical calcineurin inhibitors have been used outside their approved indications for a number of conditions, including topical steroid-induced rosacea. However, tacrolimus ointment itself has been reported to trigger rosacea in a small number of cases. We report a case of a rosacea-like eruption in a 39-year-old woman occurring after the use of pimecrolimus cream for 12 months for atopic dermatitis. Withdrawal of pimecrolimus combined with treatment with oral lymecycline, topical metronidazole, and an emollient resulted in resolution of the eruption. There have been 5 previously reported cases of a topical pimecrolimus-induced rosacea-like eruption suggesting that this rare side-effect may be a class effect of all topical calcineurin inhibitors. Dermatologists prescribing these drugs should be aware of this uncommon complication and may wish to warn patients of its occurrence as a potential side-effect when using topical calcineurin inhibitors in facial skin in adults.

Administration, Cutaneous, Adult, Dermatologic Agents, Drug Eruptions, Facial Dermatoses, Female, Humans, Peptidylprolyl Isomerase, Rosacea, Tacrolimus, Case Reports, Letter
1087-2108
1-3
El-Heis, S.
6d7d2e03-3d63-4510-8b7e-fcbe4653db13
Buckley, D A
cdba6eba-dbdc-400d-814a-b7f14e33d4ba
El-Heis, S.
6d7d2e03-3d63-4510-8b7e-fcbe4653db13
Buckley, D A
cdba6eba-dbdc-400d-814a-b7f14e33d4ba

El-Heis, S. and Buckley, D A (2015) Rosacea-like eruption due to topical pimecrolimus. Dermatology Online Journal, 21 (5), 1-3.

Record type: Letter

Abstract

Topical calcineurin inhibitors have been used outside their approved indications for a number of conditions, including topical steroid-induced rosacea. However, tacrolimus ointment itself has been reported to trigger rosacea in a small number of cases. We report a case of a rosacea-like eruption in a 39-year-old woman occurring after the use of pimecrolimus cream for 12 months for atopic dermatitis. Withdrawal of pimecrolimus combined with treatment with oral lymecycline, topical metronidazole, and an emollient resulted in resolution of the eruption. There have been 5 previously reported cases of a topical pimecrolimus-induced rosacea-like eruption suggesting that this rare side-effect may be a class effect of all topical calcineurin inhibitors. Dermatologists prescribing these drugs should be aware of this uncommon complication and may wish to warn patients of its occurrence as a potential side-effect when using topical calcineurin inhibitors in facial skin in adults.

Text
qt7kd1048m - Version of Record
Download (190kB)

More information

Published date: 18 May 2015
Keywords: Administration, Cutaneous, Adult, Dermatologic Agents, Drug Eruptions, Facial Dermatoses, Female, Humans, Peptidylprolyl Isomerase, Rosacea, Tacrolimus, Case Reports, Letter

Identifiers

Local EPrints ID: 422483
URI: http://eprints.soton.ac.uk/id/eprint/422483
ISSN: 1087-2108
PURE UUID: 64f5fde8-2053-4a30-88e1-2caa6e883bc2
ORCID for S. El-Heis: ORCID iD orcid.org/0000-0003-4277-7187

Catalogue record

Date deposited: 24 Jul 2018 16:30
Last modified: 16 Mar 2024 04:21

Export record

Contributors

Author: S. El-Heis ORCID iD
Author: D A Buckley

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×